scPharmaceuticals Inc SCPH:NASDAQ

Last Price$4.88NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+0.06(1.24%)
Bid (Size)$4.88 (1)
Ask (Size)$11.80 (1)
Day Low / High$4.79 - 4.99
Volume27.3 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 07/01/2022

 

scPharmaceuticals Inc ( NASDAQ )

Price: $4.88
Change: +0.06 (1.24%)
Volume: 27.3 K
4:00PM ET 7/01/2022
 
 

Citius Pharmaceuticals Inc ( NASDAQ )

Price: $0.89
Change: -0.03 (2.82%)
Volume: 694.5 K
4:00PM ET 7/01/2022
 
 

Viracta Therapeutics Inc ( NASDAQ )

Price: $3.67
Change: -0.21 (5.41%)
Volume: 231.8 K
4:00PM ET 7/01/2022
 
 

Spectrum Pharmaceuticals Inc ( NASDAQ )

Price: $0.77
Change: -0.01 (1.33%)
Volume: 1.7 M
4:00PM ET 7/01/2022
 
 

Puma Biotechnology Inc ( NASDAQ )

Price: $2.78
Change: -0.07 (2.46%)
Volume: 289.8 K
4:00PM ET 7/01/2022
 

Read more news Recent News

--SVB Securities Adjusts scPharmaceuticals' Price Target to $6 from $5, Keeps Market Perform Rating
8:42AM ET 5/17/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

ScPharmaceuticals Says FDA Approves New Drug Application for Furoscix to Treat Heart Disease
9:27AM ET 5/16/2022 MT Newswires

ScPharmaceuticals (SCPH) said Monday its new drug application for Furoscix has been approved by the Food and Drug Administration. Furoscix is a formulation...

scPharmaceuticals Resubmits FUROSCIX New Drug Application to US FDA
7:15AM ET 4/11/2022 MT Newswires

scPharmaceuticals (SCPH) resubmitted its new drug application to the U.S. Food and Drug Administration to seek marketing approval for FUROSCIX for the...

--SVB Leerink Starts scPharmaceuticals at Market Perform with $6 Price Target
7:44AM ET 9/09/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

scPharmaceuticals: We Still See A High Probability Of Success For FUROSCIX
8:00AM ET 8/26/2021 Seeking Alpha

Company Profile

Business DescriptionscPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA. View company web site for more details
Address2400 District Avenue
Burlington, Massachusetts 01830
Phone+1.617.517.0730
Number of Employees23
Recent SEC Filing06/15/20228-K
President, Chief Executive Officer, CFO & DirectorJohn H. Tucker
Senior VP-Clinical Development & Medical AffairsJohn Mohr
Senior Vice President-Technical OperationsMike Hassman
Chief Accounting Officer & SVP-FinanceRachael Nokes

Company Highlights

Price Open$4.87
Previous Close$4.82
52 Week Range$3.48 - 7.28
Market Capitalization$133.6 M
Shares Outstanding27.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.05
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-48.17%

Analyst Ratings as of 06/09/2022

Buy
1
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset